Skip to main content

RFG Advisory, LLC

Position in NVO — Novo Nordisk A S

CIK 1633387 BIRMINGHAM, AL

Position in NVO

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$3,170,511
+$1,547,154 QoQ
Shares Held
66,135
+49.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#291
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RFG Advisory, LLC holds $46,810,911 across 13 Drug Manufacturers - General names. NVO ranks #5 (6.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVO
Novo Nordisk A S
This page
66,135 $3,170,511

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,170,511 66,135
2026-03-31 $1,623,357 44,173
2025-12-31 $1,932,829 37,988
2025-09-30 $2,994,684 53,968
2025-06-30 $3,616,717 52,401
2025-03-31 $3,389,366 48,810
2024-12-31 $1,034,304 12,024
2024-09-30 $2,420,454 20,328
2024-06-30 $1,587,697 11,123
2024-03-31 $1,379,272 10,742
2023-12-31 $611,079 5,907
2023-09-30 $640,126 7,039
2023-06-30 $599,256 3,703
2023-03-31 $575,450 3,616
2022-12-31 $496,021 3,665
2022-09-30 $366,738 3,681
2022-06-30 $399,922 3,589
2022-03-31 $397,781 3,582
2021-12-31 $394,240 3,520
2021-09-30 $339,395 3,535
2021-06-30 $295,205 3,524
2021-03-31 $241,633 3,584
2020-12-31 $243,916 3,492
2020-09-30 $256,335 3,692
2020-06-30 $245,288 3,746
2020-03-31 $222,800 3,701